Pay in 4 interest-free payments of $5.40 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
Avoid use if you have severe kidney disease or are on dialysis unless closely supervised by a nephrologist
2 In the SURMOUNT-1 trial, 25.9% of tirzepatide participants experienced nausea, and 4.37.1% discontinued due to adverse events (depending on dose)
The company also argues that Rejuva could be easier to tolerate, since the therapy would really only stimulate added production in response to food, as opposed to the high circulating levels of GLP-1 induced by drugs
By targeting the psychological, emotional, and behavioral factors that contribute to weight gain, we empower you to adopt healthier habits and experience lasting aesthetic and health improvements
Learn more about Blue Cross Blue Shield of Michigan's commitment to affordability here
